Who is sponsoring NCT04457557?

NCT04457557 is sponsored by Ajou University School of Medicine.

What drugs are being tested in NCT04457557?

Interventions in NCT04457557: Reduced concentration of local anesthetic (ropivacaine), Usual concentration of local anesthetic (ropivacaine).

What condition does NCT04457557 study?

NCT04457557 studies Rebound Pain.

Is NCT04457557 still recruiting?

NCT04457557 is currently status unknown. Last updated 30 September 2022.

Last reviewed 2022-09-30 · How we verify

NCT04457557

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Local Anesthetic Concentration and Rebound Pain

Status unknown NA Last updated 30 September 2022

What this trial tests

NA trial testing Reduced concentration of local anesthetic (ropivacaine) in Rebound Pain in 60 participants. Status unknown.

Timeline

10 July 2020

Primary endpoint
30 June 2023

31 July 2023

Quick facts

Lead sponsor	Ajou University School of Medicine
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	60
Start date	10 July 2020
Primary completion	30 June 2023
Estimated completion	31 July 2023
Sites	1 location across South Korea

Drugs / interventions tested

Reduced concentration of local anesthetic (ropivacaine)
Usual concentration of local anesthetic (ropivacaine)

Conditions studied

Rebound Pain — all drugs for Rebound Pain →

Sponsor

Ajou University School of Medicine

Who can join

Adults 19 to 70, any sex, with Rebound Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rebound pain after nerve block could interfere with patient's recovery and rehabilitation. It is not known how local anesthetic concentrations affect rebound pain. The aim of this study is evaluation of the effect of local anesthetic concentration on rebound pain after interscalene block for shoulder surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rebound Pain

Currently open trials in the same condition.

NCT07196631 — Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain · Phase 4 · active not recruiting
NCT06382896 — Effect of Oliceridine on Rebound Pain · recruiting

Other Ajou University School of Medicine trials

Trials by the same sponsor.

NCT07101380 — Feasibility Study of 'SuperBrain BOOM' for Mild Cognitive Impairment Patients · NA · recruiting
NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
NCT06964217 — Immediate Fracture Risk After Antihypertensive Drug Initiation · not yet recruiting
NCT05751603 — Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex · NA · not yet recruiting
NCT07479160 — Heart to Heart Web-based Communication Program for Heart Failure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04457557 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ajou University School of Medicine
Last refreshed: 30 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457557.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing